Emcure Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 22, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	344,408	302,490	203,202	-	-	-
Market Cap Growth	37.44%	48.86%	-	-	-	-
Enterprise Value	358,412	315,376	214,615	-	-	-
Last Close Price	1814.85	1595.95	1070.59	-	-	-
PE Ratio	37.26	32.72	29.82	-	-	-
PS Ratio	3.74	3.29	2.57	-	-	-
PB Ratio	6.92	6.08	4.38	-	-	-
P/TBV Ratio	8.95	7.86	5.81	-	-	-
P/FCF Ratio	59.08	51.89	32.26	-	-	-
P/OCF Ratio	36.50	32.06	23.86	-	-	-
EV/Sales Ratio	3.89	3.43	2.72	-	-	-
EV/EBITDA Ratio	20.04	17.63	15.20	-	-	-
EV/EBIT Ratio	26.09	22.96	19.79	-	-	-
EV/FCF Ratio	61.48	54.10	34.07	-	-	-
Debt / Equity Ratio	0.31	0.31	0.22	0.75	0.88	1.05
Debt / EBITDA Ratio	0.85	0.85	0.70	1.91	1.99	1.68
Debt / FCF Ratio	2.61	2.61	1.62	2.84	6.55	5.69
Net Debt / Equity Ratio	0.28	0.28	0.17	0.60	0.71	0.97
Net Debt / EBITDA Ratio	0.77	0.77	0.56	1.58	1.65	1.59
Net Debt / FCF Ratio	2.36	2.36	1.26	2.27	5.30	5.27
Asset Turnover	1.03	1.03	0.99	0.92	0.94	0.91
Inventory Turnover	1.67	1.67	1.80	1.66	1.54	1.47
Quick Ratio	0.71	0.71	0.86	0.75	0.72	0.51
Current Ratio	1.43	1.43	1.71	1.33	1.27	1.16
Return on Equity (ROE)	19.57%	19.57%	18.23%	18.28%	23.59%	31.35%
Return on Assets (ROA)	9.62%	9.62%	8.45%	7.92%	9.04%	10.54%
Return on Invested Capital (ROIC)	16.23%	17.05%	15.16%	13.97%	15.92%	18.40%
Return on Capital Employed (ROCE)	24.10%	24.10%	19.50%	20.00%	25.20%	35.00%
Earnings Yield	2.68%	3.06%	3.35%	-	-	-
FCF Yield	1.69%	1.93%	3.10%	-	-	-
Dividend Yield	0.17%	0.23%	0.28%	-	-	-
Payout Ratio	6.15%	6.15%	-	10.89%	6.80%	8.19%
Buyback Yield / Dilution	-1.33%	-1.33%	-3.41%	-0.01%	-	-
Total Shareholder Return	-1.16%	-1.11%	-3.13%	-0.01%	-	-